A Systematic Review of the Role of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in the Treatment of Solid Tumors

Chimeric antigen receptor T (CAR-T) cell therapy utilizes patients' own T lymphocytes that are engineered to attack cancer cells. It is Food and Drug Administration (FDA)-approved in various hematological malignancies and currently being evaluated in solid cancers in early phase studies. We did...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Raheel S, Sardar, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122224/
https://www.ncbi.nlm.nih.gov/pubmed/34007747
http://dx.doi.org/10.7759/cureus.14494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122224/
https://www.ncbi.nlm.nih.gov/pubmed/34007747
http://dx.doi.org/10.7759/cureus.14494

Ejemplares similares